167 related articles for article (PubMed ID: 36546583)
1. 3D deep convolution neural network for radiation pneumonitis prediction following stereotactic body radiotherapy.
Kapoor R; Sleeman W; Palta J; Weiss E
J Appl Clin Med Phys; 2023 Mar; 24(3):e13875. PubMed ID: 36546583
[TBL] [Abstract][Full Text] [Related]
2. Multi-institutional dose-segmented dosiomic analysis for predicting radiation pneumonitis after lung stereotactic body radiation therapy.
Adachi T; Nakamura M; Shintani T; Mitsuyoshi T; Kakino R; Ogata T; Ono T; Tanabe H; Kokubo M; Sakamoto T; Matsuo Y; Mizowaki T
Med Phys; 2021 Apr; 48(4):1781-1791. PubMed ID: 33576510
[TBL] [Abstract][Full Text] [Related]
3. Correlation of dosimetric factors with the development of symptomatic radiation pneumonitis in stereotactic body radiotherapy.
Ryckman JM; Baine M; Carmicheal J; Osayande F; Sleightholm R; Samson K; Zheng D; Zhen W; Lin C; Zhang C
Radiat Oncol; 2020 Feb; 15(1):33. PubMed ID: 32054487
[TBL] [Abstract][Full Text] [Related]
4. Deep-Learning Model Prediction of Radiation Pneumonitis Using Pretreatment Chest Computed Tomography and Clinical Factors.
Lee JH; Kang MK; Park J; Lee SJ; Kim JC; Park SH
Technol Cancer Res Treat; 2024; 23():15330338241254060. PubMed ID: 38752262
[No Abstract] [Full Text] [Related]
5. The risk and predictors for severe radiation pneumonitis in lung cancer patients treated with thoracic reirradiation.
Ren C; Ji T; Liu T; Dang J; Li G
Radiat Oncol; 2018 Apr; 13(1):69. PubMed ID: 29661254
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of Radiation Pneumonitis After Stereotactic Body Radiotherapy: Effect of Pulmonary Emphysema Quantitated Using CT Images.
Yamamoto T; Kadoya N; Sato Y; Matsushita H; Umezawa R; Kubozono M; Ishikawa Y; Kozumi M; Takahashi N; Morishita Y; Katagiri Y; Sato K; Ito K; Takeda K; Jingu K
Clin Lung Cancer; 2018 Jan; 19(1):e85-e90. PubMed ID: 28655592
[TBL] [Abstract][Full Text] [Related]
7. Image masking using convolutional networks improves performance classification of radiation pneumonitis for non-small cell lung cancer.
Kawahara D; Imano N; Nishioka R; Nagata Y
Phys Eng Sci Med; 2023 Jun; 46(2):767-772. PubMed ID: 36976438
[TBL] [Abstract][Full Text] [Related]
8. Clinical and dosimetric predictors of radiation pneumonitis in a large series of patients treated with stereotactic body radiation therapy to the lung.
Baker R; Han G; Sarangkasiri S; DeMarco M; Turke C; Stevens CW; Dilling TJ
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):190-5. PubMed ID: 22929858
[TBL] [Abstract][Full Text] [Related]
9. Radiation pneumonitis prediction after stereotactic body radiation therapy based on 3D dose distribution: dosiomics and/or deep learning-based radiomics features.
Huang Y; Feng A; Lin Y; Gu H; Chen H; Wang H; Shao Y; Duan Y; Zhuo W; Xu Z
Radiat Oncol; 2022 Nov; 17(1):188. PubMed ID: 36397060
[TBL] [Abstract][Full Text] [Related]
10. A dose-volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy.
Barriger RB; Forquer JA; Brabham JG; Andolino DL; Shapiro RH; Henderson MA; Johnstone PA; Fakiris AJ
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):457-62. PubMed ID: 21035956
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for symptomatic radiation pneumonitis after stereotactic body radiation therapy (SBRT) in patients with non-small cell lung cancer.
Liu Y; Wang W; Shiue K; Yao H; Cerra-Franco A; Shapiro RH; Huang KC; Vile D; Langer M; Watson G; Bartlett G; Ai H; Sheski F; Jin JY; Zellars R; Fu P; Lautenschlaeger T; Kong FS
Radiother Oncol; 2021 Mar; 156():231-238. PubMed ID: 33096168
[TBL] [Abstract][Full Text] [Related]
12. Radiation pneumonia predictive model for radiotherapy in esophageal carcinoma patients.
Sheng L; Zhuang L; Yang J; Zhang D; Chen Y; Zhang J; Wang S; Shan G; Du X; Bai X
BMC Cancer; 2023 Oct; 23(1):988. PubMed ID: 37848844
[TBL] [Abstract][Full Text] [Related]
13. Dose--volume metrics associated with radiation pneumonitis after stereotactic body radiation therapy for lung cancer.
Matsuo Y; Shibuya K; Nakamura M; Narabayashi M; Sakanaka K; Ueki N; Miyagi K; Norihisa Y; Mizowaki T; Nagata Y; Hiraoka M
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e545-9. PubMed ID: 22436782
[TBL] [Abstract][Full Text] [Related]
14. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis.
Claude L; Pérol D; Ginestet C; Falchero L; Arpin D; Vincent M; Martel I; Hominal S; Cordier JF; Carrie C
Radiother Oncol; 2004 May; 71(2):175-81. PubMed ID: 15110451
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric Factors and Radiomics Features Within Different Regions of Interest in Planning CT Images for Improving the Prediction of Radiation Pneumonitis.
Jiang W; Song Y; Sun Z; Qiu J; Shi L
Int J Radiat Oncol Biol Phys; 2021 Jul; 110(4):1161-1170. PubMed ID: 33548340
[TBL] [Abstract][Full Text] [Related]
16. Prediction of Radiation Pneumonitis With Machine Learning in Stage III Lung Cancer: A Pilot Study.
Yakar M; Etiz D; Metintas M; Ak G; Celik O
Technol Cancer Res Treat; 2021; 20():15330338211016373. PubMed ID: 33969761
[TBL] [Abstract][Full Text] [Related]
17. Study of the predictors for radiation pneumonitis in patient with non-small cell lung cancer received radiotherapy after pneumonectomy.
Yu JH; Wang CL; Liu Y; Wang JM; Lv CX; Liu J; Zhang Q; Fu XL; Cai XW
Cancer Radiother; 2021 Jun; 25(4):323-329. PubMed ID: 33446419
[TBL] [Abstract][Full Text] [Related]
18. Prediction of radiation pneumonitis after definitive radiotherapy for locally advanced non-small cell lung cancer using multi-region radiomics analysis.
Kawahara D; Imano N; Nishioka R; Ogawa K; Kimura T; Nakashima T; Iwamoto H; Fujitaka K; Hattori N; Nagata Y
Sci Rep; 2021 Aug; 11(1):16232. PubMed ID: 34376721
[TBL] [Abstract][Full Text] [Related]
19. Integration of dosimetric parameters, clinical factors, and radiomics to predict symptomatic radiation pneumonitis in lung cancer patients undergoing combined immunotherapy and radiotherapy.
Nie T; Chen Z; Cai J; Ai S; Xue X; Yuan M; Li C; Shi L; Liu Y; Verma V; Bi J; Han G; Yuan Z
Radiother Oncol; 2024 Jan; 190():110047. PubMed ID: 38070685
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme inhibitors decrease the risk of radiation pneumonitis after stereotactic body radiation therapy.
Harder EM; Park HS; Nath SK; Mancini BR; Decker RH
Pract Radiat Oncol; 2015; 5(6):e643-9. PubMed ID: 26412341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
